C12Y 204/02001
Purine-nucleoside phosphorylase
Official title: Purine-nucleoside phosphorylase (2.4.2.1)
C12Y204/02001 (Purine-nucleoside phosphorylase) appears on 22 US grants and 33 published applications in this corpus.
Search patents in C12Y- Granted patents
- 22
- Published applications
- 33
- Assignees
- 22
- Inventors
- 89
- Latest grant
- 8 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 3 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 3 |
| 2003 | 4 | 4 |
| 2004 | 2 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
| 2025 | 0 | 3 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered purine nucleoside phosphorylase variant enzymes8 Oct 2024US 12,110,493 B2Codexis, Inc.
- Engineered purine nucleoside phosphorylase variant enzymes2 Nov 2021US 11,162,105 B2Codexis, Inc.
- Methods and devices to detect the presence of a condition associated with ATP depletion in a subject12 Jan 2021US 10,889,846 B2Sarissa Biomedical Limited
- Method for the synthesis of clofarabine24 Jul 2018US 10,030,043 B2Synbias Pharma AG
- Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs14 Jan 2014US 8,628,767 B2Southern Research Institute
- Method for Enzymatic Synthesis of Nucleoside Bearing Protecting Group, and Composition27 Aug 2026US 2026/0250734 A1Asymchem Life Science (Tianjin) Co., Ltd
- Method for one-pot biosynthesis of arabinonucleoside, and composition28 May 2026US 2026/0146273 A1Asymchem Life Science (Tianjin) Co., Ltd
- Enzyme immobilization carrier and preparation method therefor, immobilized enzyme and preparation method therefor, and use thereof7 May 2026US 2026/0125667 A1Asymchem Laboratories (Fuxin) Co., Ltd.
- Lipid Nanoparticles Comprising Nucleic Acids Encoding Therapeutic Genes and Uses in Medical Methods2 Apr 2026US 2026/0090997 A1
- Zikv-based gene delivery system19 Mar 2026US 2026/0078403 A1The Regents of the University of California
Most cited
By later US patents
- Oligoribonucleotides with enzymatic activity72US 6,617,438 B1Sirna Therapeutics, Inc. · 2003
- Synthetic ribonucleic acids with RNAse activity56US 6,528,640 B1Ribozyme Pharmaceuticals, Inc. · 2003
- Deprotection of RNA37US 6,054,576 ARibozyme Pharmaceuticals, Inc. · 2000
- Deprotection of RNA37US 6,303,773 B1Ribozyme Pharmaceuticals, Inc. · 2001
- Deprotection of RNA35US 6,162,909 ARibozyme Pharmaceuticals, Inc. · 2000